Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach.

Ranganna K, Selvam C, Shivachar A, Yousefipour Z. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach. Int J Mol Sci. 2020 Nov 02; 21(21).

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Apoptosis
Epigenesis, Genetic
Histone Deacetylase Inhibitors
Histone Deacetylases
Humans
Mice
Morpholines
Neoplasms
Pyrimidines
Signal Transduction

authors with profiles

Kasturi Ranganna
Amruthesh Shivachar
Zivar Yousefipour

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support